Efficacy of Percutaneous Injection of Triamcinolone in the Treatment of Mammillary Fistula

Efficacy of Percutaneous Injection of Triamcinolone in the Treatment of Mammillary Fistula


Efficacy of Percutaneous Injection of Triamcinolone in the Treatment of Mammillary Fistula

Acronym: null
Other IDs: FISTULA001
NCT Number: NCT01315080
Sponsor Collaborators: Hospital Universitario Virgen de la Arrixaca
Funding: Other


HIDRADENITIS SUPPURATIVA CLINICAL TRIAL STATUS

Recruiting Status: Recruiting
Recruiting Genders: Both
Recruiting Age Groups: Adult|Senior
Interventions:
Phases:


CLINICAL STUDY DETAILS & RESULTS

STUDY TYPES: Observational
STUDY DESIGNS: Observational Model: Case Control|Time Perspective: Prospective
Results First Received: No Study Results Posted
Study Result (if available): No Results Available
Primary Completion Date: March 2012
Outcome Measures: Resolution of mammillary fistula


CLINICAL STUDIES DATES & MILESTONES

First Received: March 11, 2011
Start Date: March 2011
Completion Date: September 2012
Last Updated: March 14, 2011
last Verified: March 2011


Source: https://ClinicalTrials.gov/show/NCT01315080


Public Domain Source: ClinicalTrials.gov query for “Hidradenitis suppurativa” clinical studies (last updated January 2016).


Tags:
0 Comments

Leave a reply

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2017 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Log in with your credentials

Forgot your details?